Koenderman AH - Search Results

1

Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase.

Bleeker WK, Teeling JL, Verhoeven AJ, Rigter GM, Agterberg J, Tool AT, Koenderman AH, Kuijpers TW, Hack CE. Bleeker WK, et al. Among authors: koenderman ah. Blood. 2000 Mar 1;95(5):1856-61. Blood. 2000. PMID: 10688848 Free article.

2

Characterization of immunoglobulin G fragments in liquid intravenous immunoglobulin products.

Diemel RV, ter Hart HG, Derksen GJ, Koenderman AH, Aalberse RC. Diemel RV, et al. Among authors: koenderman ah. Transfusion. 2005 Oct;45(10):1601-9. doi: 10.1111/j.1537-2995.2005.00549.x. Transfusion. 2005. PMID: 16181211

3

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.

Guhr T, Bloem J, Derksen NI, Wuhrer M, Koenderman AH, Aalberse RC, Rispens T. Guhr T, et al. Among authors: koenderman ah. PLoS One. 2011;6(6):e21246. doi: 10.1371/journal.pone.0021246. Epub 2011 Jun 23. PLoS One. 2011. PMID: 21731683 Free PMC article.

4

Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.

Terpstra FG, Parkkinen J, Tölö H, Koenderman AH, Ter Hart HG, von Bonsdorff L, Törmä E, van Engelenburg FA. Terpstra FG, et al. Among authors: koenderman ah. Vox Sang. 2006 Jan;90(1):21-32. doi: 10.1111/j.1423-0410.2005.00710.x. Vox Sang. 2006. PMID: 16359352

5

Viral safety of C1-inhibitor NF.

Terpstra FG, Kleijn M, Koenderman AH, Over J, van Engelenburg FA, Schuitemaker H, van 't Wout AB. Terpstra FG, et al. Among authors: koenderman ah. Biologicals. 2007 Jun;35(3):173-81. doi: 10.1016/j.biologicals.2006.08.005. Epub 2006 Oct 30. Biologicals. 2007. PMID: 17071103

6

Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step.

Koenderman AH, ter Hart HG, Prins-de Nijs IM, Bloem J, Stoffers S, Kempers A, Derksen GJ, Al B, Dekker L, Over J. Koenderman AH, et al. Biologicals. 2012 Nov;40(6):473-81. doi: 10.1016/j.biologicals.2012.07.010. Epub 2012 Aug 14. Biologicals. 2012. PMID: 22901944

7

The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial.

Heeres M, Visser T, van Wessem KJ, Koenderman AH, Strengers PF, Koenderman L, Leenen LP. Heeres M, et al. Among authors: koenderman ah. Trials. 2011 Oct 11;12:223. doi: 10.1186/1745-6215-12-223. Trials. 2011. PMID: 21988742 Free PMC article. Clinical Trial.

8

C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia.

Dorresteijn MJ, Visser T, Cox LA, Bouw MP, Pillay J, Koenderman AH, Strengers PF, Leenen LP, van der Hoeven JG, Koenderman L, Pickkers P. Dorresteijn MJ, et al. Among authors: koenderman ah. Crit Care Med. 2010 Nov;38(11):2139-45. doi: 10.1097/CCM.0b013e3181f17be4. Crit Care Med. 2010. PMID: 20693886 Clinical Trial.

9

Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc:N-acetyllactosaminide beta 1----3-N-acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid.

van den Eijnden DH, Koenderman AH, Schiphorst WE. van den Eijnden DH, et al. Among authors: koenderman ah. J Biol Chem. 1988 Sep 5;263(25):12461-71. J Biol Chem. 1988. PMID: 2970459 Free article.

10

Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL-60 cells.

Koenderman AH, Wijermans PW, van den Eijnden DH. Koenderman AH, et al. FEBS Lett. 1987 Sep 28;222(1):42-6. doi: 10.1016/0014-5793(87)80188-6. FEBS Lett. 1987. PMID: 2958363 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page